PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180687
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180687
Naloxone Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Naloxone is an opioid antagonist designed to rapidly reverse opioid overdose. Naloxone can restore the normal respiration of a person whose breathing has stopped or slowed down due to opioid or heroin overdose. Currently, opioid abuse is one of the foremost causes of drug overdose and is a leading cause of death globally. However, it is more common in North America and Europe. The opioid crisis in the U.S. has reached epidemic proportions, leading to serious healthcare costs and losses of resources. The urgent need for better treatment and growth in numbers of people suffering from opioid dependence is resulting in the growth in the U.S. naloxone market. Opioid dependence is a serious concern globally, with more than 25 million people affected. The problem exists in both developed as well as developing countries but is greatest in the United States. Global naloxone market is expected to grow at a CAGR of 10.1% during the forecast period of 2022-2030.
The Increasing Prevalence of Opioid Overdoses Remains as The Most Impactful Driver
The increasing prevalence of opioid overdoses is expected to drive the growth of the naloxone market. An increasing incidence of opioid drug abuse in both the developed and developing worlds remains the key driver for the market growth of the naloxone market. On average, more than 130 people in America die each day from an opioid overdose. Opioids are a class of drugs that include even prescription drugs such as oxycodone, fentanyl, morphine, and hydrocodone. It also includes illegal drugs such as heroin or drugs sold as heroin. The use of opioids for chronic pain management has increased worldwide. This has further increased the non-medical use of opioids due to their addictive characteristics. This is expected to drive the growth of the naloxone market.
The Parenteral Segment Dominated the Formulation Market
Based on the formulation/route of administration, the naloxone market is categorized as parenteral, intranasal, and sublingual. The parenteral segment contributed highest to the market revenues. Hospitals still remain the key resort when individuals are overdosed, and parenteral remains the key preferred administration method among healthcare professionals. The sublingual route stands second followed by the parenteral route.
0.4mg/ml Most Preferred Dosage
Based on dosage/strength, the naloxone market is segmented into 0.4mg/ml, 1mg/1ml, 0.4mg/0.4ml and 4 mg/0.1 ml. 0.4mg/ml led the market revenues in 2021. However, there is only a minor difference between 4mg/0.1 ml and the other dosages, which stand second in terms of 2021 revenues. The most recommended injections are dosed as 0.4mg at the start of the treatment.
APAC to Grow Fastest During the Forecast Period
After scrutiny of the naloxone market, regional trends, market sizes, and the overall growth paired with the latest and anticipated events, Asia Pacific is observed to be the most attractive region for the naloxone market owing to a swift growth in the uptake of medicines to prevent surging death rates. The U.S. holds the largest market owing to having the largest number of substance addicts vis a vis awareness for available options to reverse the ill effects of an overdose. Latin America is followed by North America.
Collaborations - Key Strategy among Top Market Players
Indivior remains at the top position with respect to product portfolio and business strength. Currently Indivior hold maximum number of products directly and indirectly related to naloxone, for instance, Suboxone, Sublocade and Subutex. Soboxne patent has expired and hence generic products are being introduced in the market. The key strategies followed by the company includes collaborations to understand the key market segments. For instance, Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder. The company also received approval for SUBUTEX® prolonged release solution for injection, 100mg and 300mg for substitution treatment of opioid dependence in Sweden. The company is also significantly active in tackling stigma in patients with opioid use disorder.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Naloxone market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Naloxone market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Route of Administration
Parenteral
Intranasal
Sublingual
Dosage
0.4mg/ml
1mg/1 ml
0.4 mg/0.4 ml
Sales Channel
Hospitals Pharmacy
Outpatient Retail Pharmacy
Online Pharmacy
Others
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Naloxone market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Naloxone market?
Which is the largest regional market for Naloxone market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Naloxone market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Naloxone market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Naloxone Market
- 2.2. Global Naloxone Market, By Route of Administration, 2021 (US$ Million)
- 2.3. Global Naloxone Market, By Dosage, 2021 (US$ Million)
- 2.4. Global Naloxone Market, By Sales Channel, 2021 (US$ Million)
- 2.5. Global Naloxone Market, By Geography, 2021 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2021
3. Naloxone Market: Competitive Analysis
- 3.1. Market Positioning of Key Naloxone Market Vendors
- 3.2. Strategies Adopted by Naloxone Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Naloxone Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Naloxone Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Parenteral
- 5.3.2. Intranasal
- 5.3.3. Sublingual
6. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. 0.4mg/ml
- 6.3.2. 1mg/1 ml
- 6.3.3. 0.4 mg/0.4 ml
7. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2021 Versus 2030
- 7.3. Market Segmentation
- 7.3.1. Hospitals Pharmacy
- 7.3.2. Outpatient Retail Pharmacy
- 7.3.3. Online Pharmacy
- 7.3.4. Others
8. North America Naloxone Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 8.3. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 8.4. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 8.5.Naloxone Market: By Region, 2020-2030, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 8.5.1.1.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 8.5.1.1.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 8.5.1.2.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 8.5.1.2.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 8.5.1.3.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 8.5.1.3.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Naloxone Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.3. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.4. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.Naloxone Market: By Region, 2020-2030, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.1.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.1.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.2.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.2.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.3.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.3.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.4.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.4.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.5.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.5.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 9.5.1.6.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 9.5.1.6.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Naloxone Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.3. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.4. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.Naloxone Market: By Region, 2020-2030, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.1.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.1.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.2.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.2.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.3.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.3.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.4.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.4.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.5.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.5.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 10.5.1.6.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 10.5.1.6.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Naloxone Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 11.3. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 11.4. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 11.5.Naloxone Market: By Region, 2020-2030, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 11.5.1.1.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 11.5.1.1.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 11.5.1.2.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 11.5.1.2.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 11.5.1.3.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 11.5.1.3.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Naloxone Market, 2020-2030, USD (Million)
- 12.1. Market Overview
- 12.2. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 12.3. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 12.4. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 12.5.Naloxone Market: By Region, 2020-2030, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 12.5.1.1.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 12.5.1.1.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 12.5.1.2.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 12.5.1.2.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Naloxone Market: By Route of Administration, 2020-2030, USD (Million)
- 12.5.1.3.1. Naloxone Market: By Dosage, 2020-2030, USD (Million)
- 12.5.1.3.1. Naloxone Market: By Sales Channel, 2020-2030, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. Indivior
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 2 Global Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 3 Global Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 4 North America Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 5 North America Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 6 North America Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 7 U.S. Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 8 U.S. Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 9 U.S. Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 10 Canada Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 11 Canada Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 12 Canada Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 13 Rest of North America Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 14 Rest of North America Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 15 Rest of North America Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 16 UK and European Union Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 17 UK and European Union Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 18 UK and European Union Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 19 UK Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 20 UK Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 21 UK Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 22 Germany Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 23 Germany Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 24 Germany Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 25 Spain Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 26 Spain Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 27 Spain Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 28 Italy Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 29 Italy Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 30 Italy Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 31 France Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 32 France Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 33 France Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 34 Rest of Europe Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 35 Rest of Europe Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 36 Rest of Europe Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 37 Asia Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 38 Asia Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 39 Asia Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 40 China Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 41 China Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 42 China Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 43 Japan Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 44 Japan Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 45 Japan Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 46 India Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 47 India Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 48 India Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 49 Australia Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 50 Australia Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 51 Australia Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 52 South Korea Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 53 South Korea Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 54 South Korea Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 55 Latin America Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 56 Latin America Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 57 Latin America Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 58 Brazil Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 59 Brazil Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 60 Brazil Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 61 Mexico Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 62 Mexico Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 63 Mexico Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 64 Rest of Latin America Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 65 Rest of Latin America Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 66 Rest of Latin America Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 67 Middle East and Africa Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 68 Middle East and Africa Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 69 Middle East and Africa Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 70 GCC Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 71 GCC Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 72 GCC Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 73 Africa Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 74 Africa Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 75 Africa Naloxone Market By Sales Channel, 2020-2030, USD (Million)
- TABLE 76 Rest of Middle East and Africa Naloxone Market By Route of Administration, 2020-2030, USD (Million)
- TABLE 77 Rest of Middle East and Africa Naloxone Market By Dosage, 2020-2030, USD (Million)
- TABLE 78 Rest of Middle East and Africa Naloxone Market By Sales Channel, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Naloxone Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Naloxone Market: Quality Assurance
- FIG. 5 Global Naloxone Market, By Route of Administration, 2021
- FIG. 6 Global Naloxone Market, By Dosage, 2021
- FIG. 7 Global Naloxone Market, By Sales Channel, 2021
- FIG. 8 Global Naloxone Market, By Geography, 2021
- FIG. 9 Market Geographical Opportunity Matrix - Global Naloxone Market, 2021
- FIG. 10 Market Positioning of Key Naloxone Market Players, 2021
- FIG. 11 Global Naloxone Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 12 Global Naloxone Market, By Route of Administration, 2021 Vs 2030, %
- FIG. 13 Global Naloxone Market, By Dosage, 2021 Vs 2030, %
- FIG. 14 Global Naloxone Market, By Sales Channel, 2021 Vs 2030, %
- FIG. 15 U.S. Naloxone Market (US$ Million), 2020 - 2030
- FIG. 16 Canada Naloxone Market (US$ Million), 2020 - 2030
- FIG. 17 Rest of North America Naloxone Market (US$ Million), 2020 - 2030
- FIG. 18 UK Naloxone Market (US$ Million), 2020 - 2030
- FIG. 19 Germany Naloxone Market (US$ Million), 2020 - 2030
- FIG. 20 Spain Naloxone Market (US$ Million), 2020 - 2030
- FIG. 21 Italy Naloxone Market (US$ Million), 2020 - 2030
- FIG. 22 France Naloxone Market (US$ Million), 2020 - 2030
- FIG. 23 Rest of Europe Naloxone Market (US$ Million), 2020 - 2030
- FIG. 24 China Naloxone Market (US$ Million), 2020 - 2030
- FIG. 25 Japan Naloxone Market (US$ Million), 2020 - 2030
- FIG. 26 India Naloxone Market (US$ Million), 2020 - 2030
- FIG. 27 Australia Naloxone Market (US$ Million), 2020 - 2030
- FIG. 28 South Korea Naloxone Market (US$ Million), 2020 - 2030
- FIG. 29 Rest of Asia Naloxone Market (US$ Million), 2020 - 2030
- FIG. 30 Brazil Naloxone Market (US$ Million), 2020 - 2030
- FIG. 31 Mexico Naloxone Market (US$ Million), 2020 - 2030
- FIG. 32 Rest of Latin America Naloxone Market (US$ Million), 2020 - 2030
- FIG. 33 GCC Naloxone Market (US$ Million), 2020 - 2030
- FIG. 34 Africa Naloxone Market (US$ Million), 2020 - 2030
- FIG. 35 Rest of Middle East and Africa Naloxone Market (US$ Million), 2020 - 2030
